Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026

businesswire.com
ABCL The article is a neutral announcement of AbCellera's upcoming financial results and conference call. It does not contain any information that suggests positive or negative performance.

AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026 VANCOUVER, British Columbia--( BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) will announce its first quarter 2026 financial results on Monday, May 11, 2026, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.

A live audio webcast of the earnings conference may be accessed through a link that will be posted on AbCellera’s Investor Relations website. A replay will be available through the same link following the conference call.

About AbCellera Biologics Inc.

AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody-based medicines in the areas of endocrinology, women’s health, immunology, oncology, and more. For more information, please visit www.abcellera.com.